These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 11575234
1. [Microalbuminuria in hypertensive, non-proteinuric renal transplant recipients: role of previous acute rejection episodes and sodium intake]. Halimi JM, al-Najjar A, Buchler M, Giraudeau B, Etienne I, Picou S, Marlière J, Nivet H, Lebranchu Y. Arch Mal Coeur Vaiss; 2001 Aug; 94(8):933-6. PubMed ID: 11575234 [Abstract] [Full Text] [Related]
2. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients. Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H. Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722 [Abstract] [Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group. Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [Abstract] [Full Text] [Related]
4. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? Badiou S, Garrigue V, Dupuy AM, Chong G, Cristol JP, Mourad G. Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076 [Abstract] [Full Text] [Related]
10. Is age associated with the number or types of medications prescribed to renal transplant recipients? Chisholm MA, Melroy J, Johnson M, Mulloy LL, Spivey CA. J Am Geriatr Soc; 2007 Mar 15; 55(3):389-94. PubMed ID: 17341241 [Abstract] [Full Text] [Related]
13. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group. Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398 [Abstract] [Full Text] [Related]